Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.
Plos Neglected Tropical Diseases|May 12, 2021
Endocystectomy as a conservative surgical treatment for hepatic cystic echinococcosis: A systematic review with single-arm meta-analysisMohammad Al-Saeedi, Ali Ramouz, Elias Khajeh, et al.
Plos Neglected Tropical Diseases|October 31, 2023
Risk factors and management of biliary leakage after Endocystectomy for hepatic cystic echinococcosisSepehr Abbasi Dezfouli, Ahmad El Rafidi, Ehsan Aminizadeh, et al.
Consciousness and Cognition|August 10, 2020
Sleep fragmentation and lucid dreamingJarrod Gott, Michael Rak, Leonore Bovy, et al.
Investigative Radiology|November 28, 2021
Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol StudyMarkus Wennmann, Heidi Thierjung, Fabian Bauer, et al.
The British Journal of Radiology|March 31, 2023
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myelomaMarkus Wennmann, Martin Grözinger, Vivienn Weru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Scientific Reports|December 1, 2022
Asynchronous calibration of quantitative computed tomography bone mineral density assessment for opportunistic osteoporosis screening: phantom-based validation and parameter influence evaluationStephan Skornitzke, Neha Vats, Taisiya Kopytova, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
Pageof 5